'Pharmacological Treatment of ALS'
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Sakian, Yehonatan | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház, Aneszteziológiai tanszék | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2014-06-27T13:36:29Z | |
| dc.date.available | 2014-06-27T13:36:29Z | |
| dc.date.created | 2014-03 | |
| dc.date.issued | 2014-06-27T13:36:29Z | |
| dc.description.abstract | The Article deals with the Progressive Neurodegenerative Disease ALS. It includes general background on the pathogenesis, clinical features, genetics and epidemiology. The main goal is to give a comprehensive review of the current available treatment along with the presentation of future developments and strategies from a pharmacotherapuetic point of view. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 35 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/194938 | |
| dc.language.iso | en | hu_HU |
| dc.rights.access | no_restriction | hu_HU |
| dc.subject | ALS | hu_HU |
| dc.subject | Rilozule | hu_HU |
| dc.subject | Pharmacotherapy | hu_HU |
| dc.subject | Gacyclidine | hu_HU |
| dc.subject | Dexpramipexole | hu_HU |
| dc.subject | Neurotoxicity | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány::Farmakológia | hu_HU |
| dc.title | 'Pharmacological Treatment of ALS' | hu_HU |